Liver Dihydropyrimidine Dehydrogenase Activity in Human, Cynomolgus Monkey, Rhesus Monkey, Dog, Rat and Mouse
- 15 April 1998
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 56 (5) , 276-280
- https://doi.org/10.1159/000028209
Abstract
Interspecies differences in dihydropyrimidine dehydrogenase (DPD), the initial and rate-limiting enzyme in pyrimidine degradation, were assessed in cytosol from livers isolated from human, monkey, dog, rat, and mouse. Hepatic DPD activity was measured by an HPLC assay with on-line radioactivity detection, using 14C-5-fluorouracil as a substrate. Activity was highly variable within each species and significant interspecies differences in liver DPD activity were observed. The order of activity was mouse > rat > human > dog ≥ cynomolgus monkey > rhesus monkey. These data suggest that careful selection must be made when choosing in vivo models of human DPD for the preclinical development of novel fluoropyrimidine anticancer agents and DPD inhibitors.Keywords
This publication has 3 references indexed in Scilit:
- Comparison of dihydropyrimidine dehydrogenase from human, rat, pig and cow liver: Biochemical and immunological propertiesBiochemical Pharmacology, 1993
- Degradation of pyrimidines and pyrimidine analogs—Pathways and mutual influencesPharmacology & Therapeutics, 1980
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976